hrp0095p2-177 | Growth and Syndromes | ESPE2022
Afonso Nuno
, Luísa Carvalho Ana
, Martins Sofia
, Antunes Ana
, Miguel Gomes Maria
Introduction: Somatropin has been the standard treatment for Growth hormone deficiency (GHD) since 1985. Nowadays, has been approved for the treatment of other diseases, as: Small for gestational age (SGA), Turner syndrome (TS) and Prader-Willi syndrome (PWS).Aims: Assess the efficacy of somatropin in children followed in a tertiary Hospital, at 12 and 24 months of treatment, and to compare the results based on the patie...